Evolution of the cancer genome (original) (raw)

• Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976).
  Article CAS PubMed Google Scholar
• Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
  Article CAS PubMed Google Scholar
• Vogelstein, B. & Kinzler, K. W. The multistep nature of cancer. Trends Genet. 9, 138–141 (1993).
  Article CAS PubMed Google Scholar
• Stratton, M. R., Campbell, P. J. & Futreal, P. A. The cancer genome. Nature 458, 719–724 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Campbell, P. J. et al. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc. Natl Acad. Sci. USA 105, 13081–13086 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Pleasance, E. D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191–196 (2010).
  Article CAS PubMed Google Scholar
• Ding, L. et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999–1005 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Turajlic, S. et al. Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res. 22, 196–207 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Navin, N. et al. Tumour evolution inferred by single-cell sequencing. Nature 472, 90–94 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114–1117 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Campbell, P. J. et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109–1113 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Hou, Y. et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 148, 873–885 (2012).
  Article CAS PubMed Google Scholar
• Xu, X. et al. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 148, 886–895 (2012). References 13 and 14 provide proof of principle that next-generation sequencing technologies can be combined with single-cell approaches can be used to investigate intra-tumoural heterogeneity.
  Article CAS PubMed PubMed Central Google Scholar
• Anderson, K. et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469, 356–361 (2011).
  Article CAS PubMed Google Scholar
• Baker, M. Digital PCR hits its stride. Nature Methods 9, 541–544 (2012).
  Article CAS Google Scholar
• Wang, J. et al. Quantifying EGFR alterations in the lung cancer genome with nanofluidic digital PCR arrays. Clin. Chem. 56, 623–632 (2010).
  Article CAS PubMed Google Scholar
• Anderson, A. R., Weaver, A. M., Cummings, P. T. & Quaranta, V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127, 905–915 (2006). This is a comprehensive review of the literature from the field of mathematical modelling in cancer evolution.
  Article CAS PubMed Google Scholar
• Michor, F., Iwasa, Y. & Nowak, M. A. Dynamics of cancer progression. Nature Rev. Cancer 4, 197–205 (2004).
  Article CAS Google Scholar
• Attolini, C. S. & Michor, F. Evolutionary theory of cancer. Ann. NY Acad. Sci. 1168, 23–51 (2009).
  Article CAS PubMed Google Scholar
• Ding, L. et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481, 506–510 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nature Biotech. 30, 413–421 (2012).
  Article CAS Google Scholar
• Durinck, S. et al. Temporal dissection of tumorigenesis in primary cancers. Cancer Discov. 1, 137–143 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994–1007 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979–993 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Greenman, C. D. et al. Estimation of rearrangement phylogeny for cancer genomes. Genome Res. 22, 346–361 (2012). In this article, a mathematical framework is presented for reconstructing temporal sequences of rearrangements and hence evolutionary selection.
  Article CAS PubMed PubMed Central Google Scholar
• Futreal, P. A. et al. A census of human cancer genes. Nature Rev. Cancer 4, 177–183 (2004).
  Article CAS Google Scholar
• Blanquet, V. et al. Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum. Mol. Genet. 4, 383–388 (1995).
  Article CAS PubMed Google Scholar
• Persson, M. et al. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc. Natl Acad. Sci. USA 106, 18740–18744 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ellis, M. J. et al. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 486, 353–360 (2012). This was one of the first studies to correlate somatic mutation changes identified through next-generation sequencing, with treatment responses. Somatic mutations are also mapped to distinct pathways of relevance to tumour cell biology.
  Article CAS PubMed PubMed Central Google Scholar
• Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346–352 (2012). This study is an integrated analysis of copy number and gene expression data with long-term clinical follow-up providing a novel molecular stratification of the breast cancer population.
  Article CAS PubMed PubMed Central Google Scholar
• Shah, S. P. et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486, 395–399 (2012).
  Article CAS PubMed Google Scholar
• Perreard, L. et al. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Res. 8, R23 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Parsons, D. W. et al. The genetic landscape of the childhood cancer medulloblastoma. Science 331, 435–439 (2011).
  Article CAS PubMed Google Scholar
• Zhang, J. et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature 481, 329–334 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ley, T. J. et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456, 66–72 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058–1066 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ng, C. K. et al. The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer. J. Pathol. 226, 703–712 (2012).
  Article CAS PubMed Google Scholar
• McBride, D. J. et al. Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes. J. Pathol. 227, 446–455 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Berger, M. F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214–220 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27–40 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Rausch, T. et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148, 59–71 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Molenaar, J. J. et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 483, 589–593 (2012).
  Article CAS PubMed Google Scholar
• Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643–649 (1998).
  Article CAS PubMed Google Scholar
• Pleasance, E. D. et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463, 184–190 (2010).
  Article CAS PubMed Google Scholar
• Gatenby, R. A. et al. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br. J. Cancer 97, 646–653 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Schwartz, J. L., Jordan, R., Sun, J., Ma, H. & Hsieb, A. W. Dose-dependent changes in the spectrum of mutations induced by ionizing radiation. Radiat. Res. 153, 312–317 (2000).
  Article CAS PubMed Google Scholar
• DeMarini, D. M. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat. Res. 567, 447–474 (2004).
  Article CAS PubMed Google Scholar
• Le Calvez, F. et al. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res. 65, 5076–5083 (2005).
  Article CAS PubMed Google Scholar
• Arkenau, H. T., Kefford, R. & Long, G. V. Targeting BRAF for patients with melanoma. Br. J. Cancer 104, 392–398 (2011).
  Article CAS PubMed Google Scholar
• Su, X. et al. Cascading adoptive cell therapy for metastatic melanoma. Cancer Biother. Radiopharm. 26, 401–406 (2011).
  Article CAS PubMed Google Scholar
• Coufal, N. G. et al. L1 retrotransposition in human neural progenitor cells. Nature 460, 1127–1131 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Srinivasan, D. & Plattner, R. Activation of ABL tyrosine kinases promotes invasion of aggressive breast cancer cells. Cancer Res. 66, 5648–5655 (2006).
  Article CAS PubMed Google Scholar
• Antonescu, C. R. Gastrointestinal stromal tumor (GIST) pathogenesis, familial GIST, and animal models. Semin. Diagn. Pathol. 23, 63–69 (2006).
  Article PubMed Google Scholar
• Kwon, J. G. et al. Changes in the structure and function of ICC networks in ICC hyperplasia and gastrointestinal stromal tumors. Gastroenterology 136, 630–639 (2009).
  Article PubMed Google Scholar
• Chi, P. et al. ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours. Nature 467, 849–853 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Banerji, S. et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486, 405–409 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Greenblatt, M. S., Chappuis, P. O., Bond, J. P., Hamel, N. & Foulkes, W. D. TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. Cancer Res. 61, 4092–4097 (2001).
  CAS PubMed Google Scholar
• Matsumoto, S. et al. Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene 26, 5911–5918 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Mahoney, C. L. et al. LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition. Br. J. Cancer 100, 370–375 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Jones, C. J. et al. Evidence for a telomere-independent “clock” limiting RAS oncogene-driven proliferation of human thyroid epithelial cells. Mol. Cell. Biol. 20, 5690–5699 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 (1997).
  Article CAS PubMed Google Scholar
• Jacobs, J. J. et al. Senescence bypass screen identifies TBX2, which represses CDKN2A (p19(ARF)) and is amplified in a subset of human breast cancers. Nature Genet. 26, 291–299 (2000).
  Article CAS PubMed Google Scholar
• Vance, K. W., Carreira, S., Brosch, G. & Goding, C. R. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res. 65, 2260–2268 (2005).
  Article CAS PubMed Google Scholar
• Notta, F. et al. Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells. Nature 469, 362–367 (2011).
  Article CAS PubMed Google Scholar
• Bridgham, J. T., Ortlund, E. A. & Thornton, J. W. An epistatic ratchet constrains the direction of glucocorticoid receptor evolution. Nature 461, 515–519 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Moore, J. H. A global view of epistasis. Nature Genet. 37, 13–14 (2005).
  Article CAS PubMed Google Scholar
• Bissonnette, R. P., Echeverri, F., Mahboubi, A. & Green, D. R. Apoptotic cell death induced by c-MYC is inhibited by BCL-2. Nature 359, 552–554 (1992).
  Article CAS PubMed Google Scholar
• Fanidi, A., Harrington, E. A. & Evan, G. I. Cooperative interaction between c-MYC and BCL-2 proto-oncogenes. Nature 359, 554–556 (1992).
  Article CAS PubMed Google Scholar
• Rehman, F. L., Lord, C. J. & Ashworth, A. Synthetic lethal approaches to breast cancer therapy. Nature Rev. Clin. Oncol. 7, 718–724 (2010).
  Article CAS Google Scholar
• Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917–921 (2005).
  Article CAS PubMed Google Scholar
• Swisher, E. M. et al. Secondary BRCA1 mutations in _BRCA1_-mutated ovarian carcinomas with platinum resistance. Cancer Res. 68, 2581–2586 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sakai, W. et al. Secondary mutations as a mechanism of cisplatin resistance in _BRCA2_-mutated cancers. Nature 451, 1116–1120 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641–645 (2000).
  Article CAS PubMed Google Scholar
• Bignell, G. R. et al. Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. Genome Res. 17, 1296–1303 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Rudolph, K. L., Millard, M., Bosenberg, M. W. & DePinho, R. A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nature Genet. 28, 155–159 (2001).
  Article CAS PubMed Google Scholar
• Crasta, K. et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 482, 53–58 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Magrangeas, F., Avet-Loiseau, H., Munshi, N. C. & Minvielle, S. Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients. Blood 118, 675–678 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Beerenwinkel, N. et al. Genetic progression and the waiting time to cancer. PLoS Comput. Biol. 3, e225 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Sjoblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268–274 (2006).
  Article CAS PubMed Google Scholar
• Welch, J. S. et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150, 264–278 (2012). This study presents mutational data from normal haematopoietic stem cells, which were found to show similar mutational burden and signatures to those seen in acute leukaemias.
  Article CAS PubMed PubMed Central Google Scholar
• Martin, S. A., Hewish, M., Lord, C. J. & Ashworth, A. Genomic instability and the selection of treatments for cancer. J. Pathol. 220, 281–289 (2010).
  CAS PubMed Google Scholar
• Vilar, E. & Gruber, S. B. Microsatellite instability in colorectal cancer—the stable evidence. Nature Rev. Clin. Oncol. 7, 153–162 (2010).
  Article CAS Google Scholar
• Sheltzer, J. M. et al. Aneuploidy drives genomic instability in yeast. Science 333, 1026–1030 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Solomon, D. A. et al. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333, 1039–1043 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Gordon, D. J., Resio, B. & Pellman, D. Causes and consequences of aneuploidy in cancer. Nature Rev. Genet. 13, 189–203 (2012).
  Article CAS PubMed Google Scholar
• Cheng, Y. W. et al. CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer. Clin. Cancer Res. 14, 6005–6013 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510–522 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Loeb, L. A., Bielas, J. H. & Beckman, R. A. Cancers exhibit a mutator phenotype: clinical implications. Cancer Res. 68, 3551–3557 (2008).
  Article CAS PubMed Google Scholar
• Bodmer, W., Bielas, J. H. & Beckman, R. A. Genetic instability is not a requirement for tumor development. Cancer Res. 68, 3558–3560 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Jones, D. T. et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 488, 100–105 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Pasqualucci, L. et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341–346 (2001).
  Article CAS PubMed Google Scholar
• Pasqualucci, L. et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nature Genet. 43, 830–837 (2011).
  Article CAS PubMed Google Scholar
• Migliazza, A. et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc. Natl Acad. Sci. USA 92, 12520–12524 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Bignell, G. R. et al. Signatures of mutation and selection in the cancer genome. Nature 463, 893–898 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Gandhi, M., Dillon, L. W., Pramanik, S., Nikiforov, Y. E. & Wang, Y. H. DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells. Oncogene 29, 2272–2280 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Letessier, A. et al. Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature 470, 120–123 (2011).
  Article CAS PubMed Google Scholar
• Lang, G. I. & Murray, A. W. Mutation rates across budding yeast chromosome VI are correlated with replication timing. Genome Biol. Evol. 3, 799–811 (2011).
  Article PubMed PubMed Central Google Scholar
• Veeriah, S. et al. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nature Genet. 42, 77–82 (2010).
  Article CAS PubMed Google Scholar
• Poulogiannis, G. et al. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc. Natl Acad. Sci. USA 107, 15145–15150 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Neves, H., Ramos, C., da Silva, M. G., Parreira, A. & Parreira, L. The nuclear topography of ABL, BCR, PML, and RARα genes: evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation. Blood 93, 1197–1207 (1999).
  CAS PubMed Google Scholar
• Mani, R. S. et al. Induced chromosomal proximity and gene fusions in prostate cancer. Science 326, 1230 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Lin, C. et al. Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 139, 1069–1083 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Stephens, P. J. et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462, 1005–1010 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Markowitz, S. et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268, 1336–1338 (1995).
  Article CAS PubMed Google Scholar
• Chapman, M. A. et al. Initial genome sequencing and analysis of multiple myeloma. Nature 471, 467–472 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Dunson, D. B. Nonparametric Bayes Applications to Biostatistics (Cambridge Univ. Press, 2010).
  Book Google Scholar
• Weisenberger, D. J. et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genet. 38, 787–793 (2006).
  Article CAS PubMed Google Scholar
• Flanagan, J. M. et al. Intra- and interindividual epigenetic variation in human germ cells. Am. J. Hum. Genet. 79, 67–84 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Ji, H. et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 467, 338–342 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Jones, S. et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330, 228–231 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Wiegand, K. C. et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med. 363, 1532–1543 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Dalgliesh, G. L. et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463, 360–363 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Morin, R. D. et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nature Genet. 42, 181–185 (2010).
  Article CAS PubMed Google Scholar
• Ernst, T. et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nature Genet. 42, 722–726 (2010).
  Article CAS PubMed Google Scholar
• Figueroa, M. E. et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 17, 13–27 (2010).
  Article CAS PubMed PubMed Central Google Scholar